Comparative Analysis of Cardioprotection via Stem-Cell Derived Exosomes: Induced Pluripotent and Mesenchymal Sources
Faculty Mentor
Ramaswamy Kannappan
Major/Area of Research
Pharmaceutical Sciences, Pharm.D.
Description
INTRODUCTION: Cardiovascular conditions such as myocardial infarction and heart failure both induce mitochondrial dysfunction and oxidative stress, which consequently promote the subsequent loss of cardiomyocytes. This comparative analysis will assess the cardioprotective effects of exosomes isolated from induced pluripotent stem cell-derived cardiomyocytes (ICM-Exo) and Mesenchymal cells (MSC-Exo), as these therapies target the pathways involved in inducing cellular stress, metabolic dysfunction, and cell death.
METHOD: First, we analyzed exosomes derived from iPSCs, which were used to deliver Necrostatin-1 to block the interaction between receptor-interacting protein kinase 1 (RIPK1) and RIPK3, thereby suppressing the PARP1/AIFM1 axis, preventing necroptosis, and reducing cardiomyocyte death. Then, we analyzed other exosome therapies, including ICM-Exo and MSC-Exo, to assess the varying degree of cardioprotection across different exosome sources.
RESULTS: Our comparative analysis demonstrates the overall effectiveness of stem cell-derived exosome therapies in improving left ventricular ejection fraction, reducing reactive oxygen species, and promoting myocardial structural stability. Although there were differences in both the extent and type of cardioprotective effects, these differences were attributable to the distinct mechanisms and exosome source, which consequently led to the unique cardioprotective properties of these therapies.
DISCUSSION/CONCLUSION: This analysis illustrates the potential of stem cell-derived exosomes to promote cardioprotection and how different sources and mechanisms contribute to their specific effects. These findings highlight the possibility of personalized exosome therapies tailored to target specific cardiac injuries.
Comparative Analysis of Cardioprotection via Stem-Cell Derived Exosomes: Induced Pluripotent and Mesenchymal Sources
INTRODUCTION: Cardiovascular conditions such as myocardial infarction and heart failure both induce mitochondrial dysfunction and oxidative stress, which consequently promote the subsequent loss of cardiomyocytes. This comparative analysis will assess the cardioprotective effects of exosomes isolated from induced pluripotent stem cell-derived cardiomyocytes (ICM-Exo) and Mesenchymal cells (MSC-Exo), as these therapies target the pathways involved in inducing cellular stress, metabolic dysfunction, and cell death.
METHOD: First, we analyzed exosomes derived from iPSCs, which were used to deliver Necrostatin-1 to block the interaction between receptor-interacting protein kinase 1 (RIPK1) and RIPK3, thereby suppressing the PARP1/AIFM1 axis, preventing necroptosis, and reducing cardiomyocyte death. Then, we analyzed other exosome therapies, including ICM-Exo and MSC-Exo, to assess the varying degree of cardioprotection across different exosome sources.
RESULTS: Our comparative analysis demonstrates the overall effectiveness of stem cell-derived exosome therapies in improving left ventricular ejection fraction, reducing reactive oxygen species, and promoting myocardial structural stability. Although there were differences in both the extent and type of cardioprotective effects, these differences were attributable to the distinct mechanisms and exosome source, which consequently led to the unique cardioprotective properties of these therapies.
DISCUSSION/CONCLUSION: This analysis illustrates the potential of stem cell-derived exosomes to promote cardioprotection and how different sources and mechanisms contribute to their specific effects. These findings highlight the possibility of personalized exosome therapies tailored to target specific cardiac injuries.